Cathepsin S generates soluble CX3CL1 (fractalkine) in vascular smooth muscle cells

Abstract CX3CL1 chemokine (fractalkine) is highly expressed by vascular smooth muscle cells (VSMCs) in atherosclerotic lesions. Its membrane-bound form promotes cell-cell interactions, whereas the soluble form induces chemotaxis of CX3CR1- expressing leukocytes. We show that the cysteine protease cathepsin S, expressed by VSMCs, is able to cleave membrane-anchored CX3CL1, releasing a 55-kDa fragment to the medium, thus regulating the adhesion of VSMCs and the capture of monocytes to the sites of atherogenesis. Moreover, strong co-localization of cathepsin S and CX3CL1 with a recycling endosome marker Rab11a suggests a processing of CX3CL1 in recycling endosomes during its redistribution to the plasma membrane.

[1]  Nicolas Lützner,et al.  Quantifying Cathepsin S Activity in Antigen Presenting Cells Using a Novel Specific Substrate* , 2008, Journal of Biological Chemistry.

[2]  S. Bevan,et al.  Inhibition of spinal microglial cathepsin S for the reversal of neuropathic pain , 2007, Proceedings of the National Academy of Sciences.

[3]  T. Murohara,et al.  Localization of Cysteine Protease, Cathepsin S, to the Surface of Vascular Smooth Muscle Cells by Association with Integrin ανβ3 , 2006 .

[4]  C. Mackay,et al.  Gene Profiling in Atherosclerosis Reveals a Key Role for Small Inducible Cytokines: Validation Using a Novel Monocyte Chemoattractant Protein Monoclonal Antibody , 2005, Circulation.

[5]  V. Kulasingam,et al.  Recycling of the Membrane-anchored Chemokine, CX3CL1* , 2005, Journal of Biological Chemistry.

[6]  F. Fahrenholz,et al.  The disintegrin-like metalloproteinase ADAM10 is involved in constitutive cleavage of CX3CL1 (fractalkine) and regulates CX3CL1-mediated cell-cell adhesion. , 2003, Blood.

[7]  I. Charo,et al.  Decreased atherosclerosis in CX3CR1-/- mice reveals a role for fractalkine in atherogenesis. , 2003, The Journal of clinical investigation.

[8]  P. Groot,et al.  Fractalkine Is Expressed by Smooth Muscle Cells in Response to IFN-γ and TNF-α and Is Modulated by Metalloproteinase Activity1 , 2002, The Journal of Immunology.

[9]  C. Blobel,et al.  Tumor necrosis factor-alpha-converting enzyme (ADAM17) mediates the cleavage and shedding of fractalkine (CX3CL1). , 2001, The Journal of biological chemistry.

[10]  J. Kos,et al.  Cathepsin S in tumours, regional lymph nodes and sera of patients with lung cancer: relation to prognosis , 2001, British Journal of Cancer.

[11]  K. Burnand,et al.  Expression and cellular localization of the CC chemokines PARC and ELC in human atherosclerotic plaques. , 1999, The American journal of pathology.

[12]  P. Libby,et al.  Expression of the elastolytic cathepsins S and K in human atheroma and regulation of their production in smooth muscle cells. , 1998, The Journal of clinical investigation.

[13]  Wei Wang,et al.  A new class of membrane-bound chemokine with a CX3C motif , 1997, Nature.

[14]  M. Naito,et al.  Immunohistochemical detection of macrophage‐derived foam cells and macrophage colony‐stimulating factor in pulmonary atherogenesis of cholesterol‐fed rabbits , 1995, Pathology international.

[15]  P. Libby,et al.  Expression of monocyte chemotactic protein and interleukin-8 by cytokine-activated human vascular smooth muscle cells. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.